Posts

Posted on

ADMA BREAKING INVESTIGATION: BFA Law Launches Investigation into ADMA Biologics after Short Seller Report — Investors Notified to Contact BFA Law

ADMA BREAKING INVESTIGATION: BFA Law Launches Investigation into ADMA Biologics after Short Seller Report — Investors Notified to Contact BFA Law

NEW YORK–(BUSINESS WIRE)–
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws.

If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/adma-biologics-class-action-lawsuit.

Why is ADMA Biologics Being Investigated for Securities Fraud?

ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing and developing specialty biologics. ADMA Biologics’ flagship product is ASCENIV, a liquid immune globulin solution used to treat Primary Humoral Immunodeficiency in adults and adolescents.

BFA is investigating allegations that ADMA Biologics’ reported 20% revenue growth in 2025 was driven by a channel stuffing scheme to mask deteriorating demand.

Why did ADMA Biologics’ Stock Drop?

On March 24, 2026, Culper Research, an investigative research firm, published a report titled “ADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and –3% Real Growth in 2025 vs. +20% Reported.” The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to “stock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.” This allegedly allowed ADMA Biologics to book revenue and “report[] growth that was never there.” According to Culper Research, had ADMA Biologics not engaged in this alleged channel stuffing scheme, it would have experienced revenue declines of 3% in 2025 instead of the reported 20% growth.

This news caused the price of ADMA Biologics stock to decline $3.96 per share, or 29%, over the course of two trading days, from $13.59 per share on March 23, 2026, to $9.63 per share on March 25, 2026.

Click here for more information: https://www.bfalaw.com/cases/adma-biologics-class-action-lawsuit.

What Can You Do?

If you invested in ADMA Biologics, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/adma-biologics-class-action-lawsuit

Or contact:

Adam McCall

[email protected]

212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/adma-biologics-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

Adam McCall

[email protected]

212.789.3619

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo
Posted on

ATG Capital Calls on ProCap Financial Board to Halt its Proposed Stockholder-Dilutive Merger with CFO Silvia

Highlights ISS Agreement: ISS Recommends Stockholders Vote “AGAINST” the ProCap Financial Merger and the Company’s Director Nominee

Reminds Stockholders it is Not Too Late to Make Their Voice Heard

SUNNY ISLES BEACH, Fla., March 26, 2026 (GLOBE NEWSWIRE) — ATG Capital Management LP (together with certain of its affiliates, “ATG Capital” or “we”), a stockholder of ProCap Financial, Inc. (NASDAQ: BRR) (“BRR,” “ProCap,” or the “Company”), today issued the following statement regarding ISS’s recommendations that BRR stockholders vote “AGAINST” the Company’s proposed merger with CFO Silvia, Inc. and “AGAINST” the election of the Company’s nominee for Class I director.

Note, this is not a solicitation of authority to vote any proxy. ATG Capital is not asking for your proxy card and will not accept proxy cards if sent.

On Wall Street, BRR is a digital asset treasury company that has traded at a persistent and significant discount to its net asset value — and whose Board has now undertaken an apparent self-enriching transaction that does not pass the smell test, as its terms dilute stockholders seemingly for the CEO’s benefit.

On Main Street, “brr” is an onomatopoeic interjection used to represent the sound of shivering, chattering teeth, or vocalized breathing made when a person is feeling very cold. It is a vocal signal used to communicate a freezing sensation to others, often accompanied by physically shaking or puffing out air.

Perhaps most concisely, the “brr” emoji is a freezing face.

Could ProCap Financial have chosen a more fitting ticker to capture the ProCap stockholder experience—the experience of being left out in the cold?

On March 12, ATG Capital released a public letter to ProCap’s board of directors (the “Board”), which outlined some of our concerns regarding its proposed CFO Silvia transaction. Since then, we have been pleased to hear from many stockholders who share our alarm and are also highly concerned. Since the issuing of our letter, the Company has not engaged with ATG Capital, and CEO Anthony Pompliano has gone so far as to block us on Twitter1 — a remarkable response to a stockholder raising legitimate concerns.

The information gaps between the Company’s public communications and the realities buried in its proxy filings remain wide and troubling. Stockholders deserve consistency and candor, and we believe they are receiving neither.

We are pleased to see that Institutional Shareholder Services (“ISS”) has independently agreed with our recommendation that stockholders vote “AGAINST” the CFO Silvia merger and “AGAINST” the Company’s director nominee. In issuing its recommendations, ISS found that the Company’s “public disclosure does not include adequate support for the valuation of the target,”2 and flagged inherent conflicts of interest and numerous corporate governance deficiencies.

We strongly encourage all stockholders to review the ISS report before casting their vote. If you have already voted, it is not too late to change your vote by submitting a new vote “AGAINST” the merger and “AGAINST” the Company’s director nominee today!

This situation demands action. We call on the Board to halt the merger immediately and chart a credible path toward genuine value creation for all stockholders. In our view, this process must start with a corporate governance overhaul, real transparency on treasury strategy, and the addition of independent, sizeable stockholders to the Board whose interests are properly aligned with those of all investors.

We encourage all ProCap stockholders to make their voice and concerns heard at the Company’s Annual Meeting!

ATG Capital Management LP

THIS IS NOT A SOLICITATION OF AUTHORITY TO VOTE YOUR PROXY. DO NOT SEND US YOUR PROXY CARD. ATG CAPITAL IS NOT ASKING FOR YOUR PROXY CARD AND WILL NOT ACCEPT PROXY CARDS IF SENT. ATG CAPITAL IS NOT ABLE TO VOTE YOUR PROXY, NOR DOES THIS COMMUNICATION CONTEMPLATE SUCH AN EVENT.


About ATG Capital

ATG Capital Management LP is a privately-held investment firm that manages investment vehicles for select accredited investors. ATG invests primarily in public equity markets, utilizing alternative strategies including direct and constructive engagement, in pursuit of providing superior investment returns.

Contact

ATG Capital Management LP
Gabi Gliksberg
[email protected] 


1

Given that the Company’s website points to Pompliano’s twitter account as a venue for sharing Company information, we are left wondering if this is a Reg FD violation. See https://investors.procapfinancial.com/
(“In addition to Press Releases and SEC filings, Company information may also be shared on the following social media accounts: Anthony Pompliano, CEO, on X  @APompliano and Jeff Park, Chief Investment Officer, on X  @dgt10011”).


2 Institutional Shareholder Services (“ISS”), Proxy Analysis & Benchmark Policy Recommendation: ProCap Financial, Inc. (BRR) (March 2026).



Posted on

SoFi Expands Loan Platform Business with Multiple New Agreements Totaling Over $3.6 Billion

SoFi Expands Loan Platform Business with Multiple New Agreements Totaling Over $3.6 Billion

Deals with a leading global bank, a top-five global asset manager, and a financial services and insurance group add over $3.6 billion in expected personal loan funding.

SAN FRANCISCO–(BUSINESS WIRE)–
SoFi Technologies, Inc. (NASDAQ: SOFI) today announced the expansion of its Loan Platform Business (LPB), committing over $3.6 billion in personal loan delivery across three new partnerships.

SoFi closed a LPB transaction with a leading global bank for an expected loan delivery of over $1 billion and a separate LPB transaction with a financial services and insurance group for $600 million over 12 months.

Additionally, SoFi agreed terms on a new partnership with a top-five global private asset management firm, expected to deliver up to $2 billion over a two-year period.

SoFi’s Loan Platform Business refers pre-qualified borrowers to loan origination partners as well as originates loans on behalf of third parties. These new agreements reflect the continuing strong demand for personal loans from both members and debt investors.

“Adding three new partners to our growing network shows the unique value of our Loan Platform Business to asset managers, institutional investors and partners more broadly,” said Anthony Noto, CEO of SoFi. “By connecting strong borrower demand with institutional capital, we’re building a capital-light, fee-based business that complements our overall lending business while leveraging our existing technology platform capabilities in underwriting, pricing, marketing and servicing.”

SoFi’s Loan Platform Business drives capital-light, fee-based revenue by earning fee income for originating loans for partners while retaining servicing rights. In 2025, SoFi’s Loan Platform Business secured over $10 billion in commitments to meet strong borrower demand.

About SoFi

SoFi Technologies (NASDAQ: SOFI) is a one-stop shop for digital financial services on a mission to help people achieve financial independence to realize their ambitions. 13.7 million members trust SoFi to borrow, save, spend, invest, and protect their money and buy, sell and hold their crypto – all in one app – and get access to financial planners, exclusive experiences, and a thriving community. Fintechs, financial institutions, and brands use SoFi’s technology platform Galileo to build and manage innovative financial solutions across 128 million global accounts. For more information, visit www.sofi.com or download our iOS and Android apps.

©2026 SoFi Technologies, Inc. All rights reserved.

Availability of Other Information About SoFi

Investors and others should note that we communicate with our investors and the public using our website (https://www.sofi.com), the investor relations website (https://investors.sofi.com), and on social media (X and LinkedIn), including but not limited to investor presentations and investor fact sheets, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that SoFi posts on these channels and websites could be deemed to be material information. As a result, SoFi encourages investors, the media, and others interested in SoFi to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on SoFi’s investor relations website and may include additional social media channels. The contents of SoFi’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Cautionary Statement Regarding Forward-Looking Statements

Certain of the statements above are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding expectations for the partnership between SoFi and each of the LPB partners referenced above, as well as the extension of any LPB partnerships, the amount of loans expected to be purchased in connection with any such LPB partnership, demand for SoFi products, and the financial position, business strategy and plans and objectives of management for SoFi’s future operations. These forward-looking statements are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. Words such as “expect”, “could”, “continue”, “future”, “may”, “plan”, “will”, “will be”, “will continue”, and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Factors that could cause actual results to differ materially from those contemplated by these forward-looking statements include: (i) the impact on each of SoFi’s and their LPB partners’ business as a result of the regulatory environment, changes in governmental policies, changes in personnel and resources of the governmental agencies that regulate us, and complexities with compliance related to such environment; (ii) SoFi’s ability to continue to drive brand awareness and realize the benefits of its marketing and advertising campaigns; (iii) SoFi’s ability to manage planned products effectively and expectations regarding the development and expansion of its business; (iv) SoFi’s ability to predict the demand for new products and the future of the financial services industry; (v) SoFi’s ability to develop new products, features and functionality that are competitive and meet market needs; (vi) SoFi’s ability to maintain the security and reliability of their respective products; and (vii) the outcome of any legal or governmental proceedings instituted against SoFi. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties set forth in the section titled “Risk Factors” in SoFi’s last annual report on Form 10-K as filed with the Securities and Exchange Commission, and those that are included in any future filings with the Securities and Exchange Commission. These forward-looking statements are based on information available as of the date hereof and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing SoFi’s views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

SOFI-F

Media Contacts

SoFi: [email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Fintech Professional Services Finance

MEDIA:

Logo
Logo
Posted on

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Super Micro Computer, Inc. (SMCI) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm 

ATLANTA, March 26, 2026 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Super Micro Computer, Inc. (“Super Micro”) (NASDAQ: SMCI). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding Super Micro’s business, operations, and prospects, including allegations that: (1) a significant portion of Super Micro’s sales of servers were to companies based in China; (2) these transactions violated U.S. export control laws; and (3) there were material weaknesses in Super Micro’s controls to ensure compliance with applicable export control laws and regulations.

If you purchased Super Micro shares between April 30, 2024 and March 19, 2026, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/super-micro-computer/ for more information. 

The deadline to ask the court to be appointed lead plaintiff in the case is May 26, 2026. 

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq. 
(888) 508-6832 (toll-free)
[email protected]



Posted on

Travel + Leisure Co. Completes $325 Million Term Securitization

Travel + Leisure Co. Completes $325 Million Term Securitization

ORLANDO, Fla.–(BUSINESS WIRE)–Travel + Leisure Co. (NYSE:TNL) announced today it completed a term securitization transaction involving the issuance of $325 million in principal amount of asset-backed notes with an overall weighted average coupon of 5.11%. The advance rate for this transaction was 98.00%.

“This transaction reflects the consistency of our platform and our ability to access capital even in a more volatile market environment,” said Erik Hoag, Chief Financial Officer of Travel + Leisure Co. “We’re pleased with both the execution and the terms achieved, which strengthen our liquidity and position us well as we move through 2026.”

Sierra Timeshare 2026-1 Receivables Funding LLC issued $150 million of Class A Notes, $58 million of Class B Notes, $70 million of Class C Notes, and $47 million of Class D Notes. The Class A Notes have a coupon of 4.56%, the Class B Notes have a coupon of 4.80%, the Class C Notes have a coupon of 5.19%, and the Class D Notes have a coupon of 7.10%.

Sierra Timeshare 2026-1 Receivables Funding LLC is an indirect subsidiary of Travel + Leisure Co. The transaction was completed in reliance upon Rule 144A and Regulation S as a placement of securities not registered under the Securities Act of 1933, as amended, or any state securities law. All of such securities having been sold, this announcement of their sale appears as a matter of record only.

About Travel + Leisure Co.

Travel + Leisure Co. (NYSE: TNL) is a leading leisure travel company, providing more than six million vacations to travelers around the world every year. The company operates a diverse portfolio of vacation ownership, travel club, and lifestyle travel brands designed to meet the needs of the modern leisure traveler, whether they’re traversing the globe or enjoying destinations closer to home. This includes experiential brands such as Sports Illustrated Resorts, Eddie Bauer Adventure Club, Margaritaville Vacation Club, and Accor Vacation Club, as well as cornerstone brands, Club Wyndham, WorldMark, and RCI. With hospitality and responsible tourism at its heart, the company’s more than 19,000 dedicated associates worldwide help fulfill its mission to put the world on vacation. Learn more at travelandleisureco.com.

Investors:

Investor Relations

[email protected]

Media Contact:

Public Relations

[email protected]

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS: Other Consumer Family Other Travel Lifestyle Consumer Lodging Vacation Destinations Tourist Attractions Travel

MEDIA:

Logo
Logo
Posted on

SLB Announces Dates for First-Quarter 2026 Results Conference Call

SLB Announces Dates for First-Quarter 2026 Results Conference Call

HOUSTON–(BUSINESS WIRE)–
SLB (NYSE:SLB) will hold a conference call on April 24, 2026, to discuss the results for the first quarter ending March 31, 2026.

The conference call is scheduled to begin at 11:00 a.m. US Eastern time and a press release regarding the results will be issued at 7:00 a.m. US Eastern time.

To access the conference call, listeners should contact the Conference Call Operator at +1 (833) 470-1428 within North America or +1 (404) 975-4839 outside of North America approximately 10 minutes prior to the start of the call and the access code is 742955.

A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/972985185 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until May 1, 2026, and can be accessed by dialing +1 (866) 813-9403 within North America or +1 (929) 458-6194 outside of North America and giving the access code 360731.

About SLB

SLB (NYSE: SLB) is a global technology company that has driven energy innovation for 100 years. With a global footprint in more than 100 countries and employees representing almost twice as many nationalities, we work each day on innovating oil and gas, delivering digital at scale, decarbonizing industries, and developing and scaling new energy systems that accelerate the energy transition. Find out more at slb.com.

Investors

James R. McDonald – SVP of Investor Relations & Industry Affairs

Joy V. Domingo – Director of Investor Relations

SLB

Tel: +1 (713) 375-3535

[email protected]

Media

Josh Byerly – SVP of Communications

Moira Duff – Director of External Communications

SLB

Tel: +1 (713) 375-3407

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Data Management Technology Manufacturing Other Energy Utilities Other Technology Other Manufacturing Oil/Gas Energy Engineering Machinery

MEDIA:

Logo
Logo
Posted on

Wells Fargo Reaches Major Digital Milestones

Wells Fargo Reaches Major Digital Milestones

Customers embrace mobile and AI-powered banking

SAN FRANCISCO–(BUSINESS WIRE)–
Wells Fargo today announced significant milestones in its digital transformation, underscoring growing customer adoption of its mobile banking platform and AI‑powered virtual assistant, Fargo®. Fargo has now supported customers through more than 1 billion interactions – achieved in less than three years since its launch. Additionally, the company surpassed 33 million mobile active users last month.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326542274/en/

Wells Fargo

Wells Fargo

These milestones reflect scale and trust as millions of customers increasingly rely on Wells Fargo’s digital tools to manage everyday financial needs quickly, securely, and with greater personalization.

“Reaching one billion Fargo interactions is a meaningful milestone because it represents how customers are choosing to engage with us every day,” said Michelle Moore, head of Digital Data and Artificial Intelligence at Wells Fargo. “It reflects our disciplined approach to responsibly scaling AI and delivering experiences that make banking easier, smarter, and more personal.”

By combining intuitive design with responsible use of artificial intelligence, Fargo allows customers to accomplish more through natural, conversational interactions—reducing friction and saving time.

The Wells Fargo Mobile® app continues to receive strong customer feedback, earning a 4.9‑star rating in the App Store from more than 10 million reviews. Since its debut in 2023, Fargo has become a central part of that experience, helping customers complete common banking tasks such as sending money with Zelle®, paying bills, locating routing numbers, and gaining insights into spending and account balances.

Wells Fargo’s digital tools are also helping expand access to banking services. More than 3 million Spanish‑speaking customers have used Fargo, engaging with the virtual assistant over 160 million times, reinforcing the company’s focus on building inclusive, easy‑to‑use experiences for a broad range of customers.

Zelle® and the Zelle® related marks are wholly owned by Early Warning Services, LLC and are used herein under license.

About Wells Fargo

Wells Fargo & Company (NYSE: WFC) is a leading financial services company that has approximately $2.1 trillion in assets. We provide a diversified set of banking, investment and mortgage products and services, as well as consumer and commercial finance, through our four reportable operating segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth & Investment Management. Wells Fargo ranked No. 33 on Fortune’s 2025 rankings of America’s largest corporations. News, insights, and perspectives from Wells Fargo are also available at Wells Fargo Stories.

Additional information may be found at www.wellsfargo.com

LinkedIn: https://www.linkedin.com/company/wellsfargo

News Release Category: WF-(IT)

Media

Julia Tunis Bernard, 415-385-0356

[email protected]

(or)

Investor Relations

John Campbell, 415-396-0523

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Apps/Applications Mobile/Wireless Technology Finance Fintech Banking Professional Services Software Digital Cash Management/Digital Assets Artificial Intelligence

MEDIA:

Photo
Photo
Wells Fargo
Posted on

Office Fit-Out Costs Across the Americas Rise 5.5% as Contractors Expect Further Increases, According to Cushman & Wakefield’s 2026 Cost Guide

Office Fit-Out Costs Across the Americas Rise 5.5% as Contractors Expect Further Increases, According to Cushman & Wakefield’s 2026 Cost Guide

NEW YORK–(BUSINESS WIRE)–
Cushman & Wakefield has released its 2026 Americas Office Fit Out Cost Guide, covering 59 markets and providing benchmarks to help occupiers plan capital investments and relocation budgets.

Office fit-out costs across the Americas increased 5.5% year-over-year to an average of $149 per square foot. Most general contractors expect labor and material costs to continue rising over the next six months, with 79% anticipating increases and none expecting declines.

Though some markets exhibit pockets of strong demand, the office pipeline has fallen to a 25-year low. Overall construction activity remains subdued, yet fit-out costs continue to rise.

Key Findings

  • Fit-out costs increased to $149 per square foot

    • Average costs rose 5.5% year-over-year, with most countries seeing price growth broadly aligned with national inflation.

  • No near-term relief expected

    • 79% of contractors expect labor and material costs to rise over the next six months. None expect declines.

  • Contractors are absorbing more cost pressure

    • 83% expect suppliers to raise prices, but only 63% expect to increase their own pricing. 20% expect to absorb higher costs, up from 13%.

  • Office construction remains limited

    • The development pipeline is at a 25-year low, with overall activity subdued.

  • Wide fit-out cost variation across markets

    • San Francisco ($228 psf), San Jose ($224 psf) and Seattle ($223 psf) are the most expensive markets.

    • Argentina ($57 psf), Brazil ($79 psf) and Colombia ($84 psf) are the most cost-effective.

“Office fit-out costs continued to increase across the Americas in 2026, even as construction activity remained subdued,” said Andy Jansen, President of Project & Development Services at Cushman & Wakefield. “Contractors still expect labor and material costs to rise in the near term, with no expectation of declines.”

Cost Drivers and Market Conditions

Higher costs in Western U.S. markets reflect elevated labor expenses, strong union presence, strict building and energy codes, seismic requirements, and higher operating and insurance costs.

Commodity prices eased after 2022 but increased over the past year, particularly copper and concrete. Copper demand is being driven by electrification, including electric vehicles, data centers and power infrastructure. Tariffs on imported materials are expected to keep domestic pricing elevated.

Labor remains a key constraint. Construction employment growth across North America was minimal in 2025, while wage growth remained elevated and continued to outpace employment growth.

Electrical work accounts for the largest share of fit-out costs at 24% of total project expenses. Architectural millwork represents the smallest share at 3%.

Office Leasing and Tenant Improvement Trends

Class A tenant improvement allowances are increasing as landlords compete for high-credit tenants and respond to higher build-out costs. Occupiers are also demanding higher-end finishes, more collaborative layouts and integrated amenities, all of which increase project complexity.

Leasing activity remains selective, with demand concentrated in trophy and Class A buildings. In many major markets, Class A leasing has matched or exceeded pre-pandemic levels.

“The guide shows that office build-out decisions are being shaped by persistent cost pressure, selective demand and wide market variation,” said Jansen. “Costs continue to depend heavily on location, labor conditions and project scope.”

Regional Highlights

  • United States

    • Fit-out costs increased about 5% year-over-year. The Northeast led growth at 7%, while the Midwest saw the lowest increase at 2.1%. The Tri-State region recorded the highest average costs at $193 psf.

  • Canada

    • Costs have moderated from pandemic peaks but remain elevated, with a higher baseline driven by labor constraints, wage growth and trade uncertainty.

  • Latin America

    • Latin America remains the most cost-competitive region at $108 psf, followed by Mexico at $119 psf, reflecting lower labor costs and less complex regulatory environments.

Brazil, Boston and Los Angeles recorded the largest year-over-year increases at 50%, 19% and 15%, respectively. Montreal, Toronto, Minneapolis, Detroit and Costa Rica saw declines. Gateway markets averaged $196 psf, about 21% above the U.S. average of $162 psf.

Click here to read the report: https://www.cushmanwakefield.com/en/insights/office-fit-out-cost-guide

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for occupiers and investors with approximately 53,000 employees in over 350 offices and nearly 60 countries. In 2025, the firm reported revenue of $10.3 billion across its core service lines of Services, Leasing, Capital markets, and Valuation and other. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit www.cushmanwakefield.com.

Media Contact:

Garrett Derderian

Vice President

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property Urban Planning REIT Landscape Interior Design Building Systems Architecture Other Construction & Property Residential Building & Real Estate

MEDIA:

Logo
Logo
Posted on

INVESTOR ALERT: Investigation of ADMA Biologics, Inc. (ADMA) Announced by Holzer & Holzer, LLC

ATLANTA, March 26, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) complied with federal securities laws. On March 24, 2026, Culper Research published a report alleging that “ADMA’s reported growth is a fiction driven more than entirely by a de facto channel stuffing scheme and an undisclosed related party distributor. We estimate that, absent channel stuffing, ADMA revenues declined 3% in 2025 vs. +20% reported.” Following this report, the price of the Company’s stock dropped.

If you purchased ADMA stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/adma-biologics/ to discuss your legal rights.  

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, https://holzerlaw.com/, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. 

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected] 



Posted on

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

  • Potential transaction expected to add $20M+ in revenue and support double-digit growth, further strengthening Tevogen’s position in oncology, rare diseases, and medical devices
  • Target CRO operates across 20+ countries, providing global clinical development capabilities

WARREN, N.J., March 26, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it is in advanced-stage evaluation of a niche contract research organization (CRO) with multi-country operations and established relationships across oncology, rare diseases, and medical devices.

If completed, the transaction would represent a meaningful step in Tevogen’s evolution toward a more diversified, revenue-generating healthcare enterprise. The opportunity is expected to contribute more than $20 million in annual revenue while supporting double-digit growth beginning next year.

The potential combination would bring together two organizations with highly complementary expertise, global reach, and a shared focus on delivering high-quality solutions to clients operating in complex and specialized therapeutic areas. The Company believes this initiative, alongside other strategic evaluations, supports its long-term objective of building a scalable, cash-flow-oriented operating model.

“I am pleased with the rapid progress towards a cash flow positive healthcare enterprise,” said Tevogen Bio CEO Dr. Ryan Saadi. “With the advanced-stage evaluation of this CRO, alongside additional acquisition opportunities under review, there may be potential to generating closer to $100 million in annual revenue, I hope to update further in the near term. These are not just financial metrics; they are the economic fundamentals required to support our core mission of delivering affordable, next-generation healthcare solutions in oncology, rare disease, and beyond, while maintaining the company’s fiscal sovereignty.”

About Tevogen

Tevogen is a socially integrated healthcare enterprise built on the principles of affordability, efficiency, and scientific rigor. The company leverages artificial intelligence and precision T cell therapy platforms, a patient-first and cost-disciplined operating model, and engagements with global technology leaders to support the development of advanced, life-saving therapies across multiple therapeutic areas and scalable solutions for the broader healthcare system.

Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. Tevogen Bio’s pipeline spans virology, oncology, and neurology, with programs built on the company’s proprietary ExacTcell™ platform.

Tevogen.AI is designed to transform drug development by accelerating target detection, helping reduce failure rates, and supporting optimized clinical trial design through proprietary predictive technologies. The platform utilizes cloud and data services from leading technology providers, including Microsoft and Databricks, to advance its long-term ambition to predict the proteome for any given protein–HLA combination, enabling rapid and cost-efficient therapeutic discovery.

Tevogen is exploring future strategic initiatives that may include domestic generics, biosimilars, medical devices, and innovative insurance solutions for healthcare providers. Together, these programs reflect Tevogen’s mission to advance sustainable innovation and broaden patient access through a faster, more efficient, and more equitable healthcare model.

Forward Looking Statements

This press release contains certain forward-looking statements, including without limitation statements relating to: the potential transaction and the potential benefits of the transaction; Tevogen’s plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen’s development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as “may,” “could,” “would,” “expect,” “anticipate,” “possible,” “potential,” “goal,” “opportunity,” “project,” “believe,” “future,” and similar words and expressions or their opposites. These statements are based on management’s expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company’s control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements.

Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: risks inherent in diligence and negotiation of the proposed transaction; the risk that the transaction may not be consummated on favorable terms or at all; the risk that the expected benefits of the transaction may not be realized on a timely basis or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen’s commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; that Tevogen will need to raise additional capital to fully realize its business plans; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen’s business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen’s limited operating history; and those factors discussed or incorporated by reference in Tevogen’s most recent Annual Report on Form 10-K and subsequent filings with the SEC.

You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law.

Contacts

Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/aa4821ea-0129-4a1a-abac-deed1a9e9799